期刊文献+

HER-2与结直肠癌的研究进展 被引量:2

Progress in research of HER-2 and colorectal cancer
原文传递
导出
摘要 表皮生长因子受体2(HER-2)是表皮生长因子受体家族的一名重要成员,对细胞生长、分化、凋亡的调节起着重要作用。随着针对胃癌HER-2癌基因靶向治疗的逐步明了,对临床医师预测患者的治疗结果、选择个体化的治疗方案提供真实可靠的依据。胃癌与结直肠癌同属消化道恶性肿瘤,期待HER-2在结直肠癌中像在胃癌中一样占据着重要的地位,本文综述了HER-2的概述、检测方法及与结直肠癌的关系。 Human epidermal growth factor receptor 2 (HER-2) is an important member of the epidermal growth factor receptor family, and plays an important role in the regulation of cell growth, differentiation and apoptosis. With better understanding of the important role of HER-2 in gastric cancer targeted therapy, clinicians could provide individual therapeutic strategies and could also predict clinical outcomes of patients. Since both gastric and colorectal cancers belong to malignant tumors of the digestive tract, we expect HER-2-targeted therapy to be effective in treating colorectal cancer as well. This paper is an overview of HER-2, detection methods and its association with colorectal cancer.
出处 《中华普外科手术学杂志(电子版)》 2016年第1期88-90,共3页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
关键词 结直肠肿瘤 受体 表皮生长因子 Colorectal neoplasms Receptor, epidermal growth factor
  • 相关文献

参考文献18

二级参考文献114

  • 1结直肠癌诊疗规范(2010年版)[J].中国医学前沿杂志(电子版),2011,3(6):130-146. 被引量:88
  • 2Mohamad Amin Pourhoseingholi.Increased burden of colorectal cancer in Asia[J].World Journal of Gastrointestinal Oncology,2012,4(4):68-70. 被引量:19
  • 3杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 4Albanell J,Codony-Servat J,Rojo F,et al.Activated extracellular signal-regulated kinases:association with epidermal growth factor receptor/transforming growth factor an expression in head and neck squamous carcinoma and inhibition by anti-epidermal growthfactor receptor treatments[J].Cancer Res,2001;61(17):6500-10.
  • 5Johnson GR,Saeki T,Gordon AW,et al.Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon[J].J Cell Biol,1992;118(3):741-51.
  • 6Jiang D,Liang J,Humphrey LE,et al.Expression of TGFα autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor[J].J Cell Physiol,1998;175(2):174-83.
  • 7Awwad RA,Sergina N,Yang H,et al.The role of transforming growth factor a in determining growth factor independence[J].Cancer Res,2003;63(15):4731-8.
  • 8Ziober BL,Willson JK,Hymphrey LE,et al.Autocrine transforming growth factor-α is associated with progression of transformed properties in human colon cancer cells[J].J Biol Chem,1993;268(1):691-8.
  • 9Hu YP,Venkateswarlu S,Sergina N,et al.Reorganization of ErbB family and cell survival signaling following knockdown of ErbB2 in colon cancer cells[J].J Biol Chem,2005;280(29):27383-92.
  • 10Wang D,Patil S,Li W,et al.Activation of the TGFa autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells[J].Oncogene,2002;21(18):2785-96.

共引文献145

同被引文献26

  • 1Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major palterns in GLOBOCAN 2012[J]. Int J Cancer,2015,136(5) :E359-386.
  • 2World Health Organization. Cancer: fact sheet [ R/OL]. ( 2014 -11 ) [ 2015-01-01 ]. http://www, who. int/mediacentre/factsheets/ fs297/en/.
  • 3Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 tes- ting in breasl cancer[ ] ]. Arch Pathol Lab Med ,2007,131 (1) :18- 43.
  • 4Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/ neu oncogene [ J]. Science, 1987,235 (4785) : 177-182.
  • 5Li C, Liu DR, Ye LY, et al. HER-2 overexpression and survival in colorectal cancer: a meta-analysis[ J]. J Zhejiang Univ Sci B, 2014,15(6) :582-589.
  • 6Snoeren N, Voest EE, Bergman AM, et al. A randomized two arm phase lII study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adju- vant treatment [ J ]. BMC Cancer ,2010,10:545.
  • 7Mukai K, Yasutomi Y, Watanabe M, et al. HER2 peptide-specific CD8 ( + ) T cells are proportionally detectable long after multiple DNA vaccinations[ Jl. Gene Ther,2002,9(13) :879-888.
  • 8Baxevanis CN, Sotiriadou NN, Gritzapis AD, et al. Immunogenic HER-2/neu peptides as tumor vaccines [ J ]. Cancer Immunol Im- munother,2006,55 ( 1 ) :85-95.
  • 9张凯,王中义,David Zhang,李春,生李红,刘铜军.HER2在结直肠癌中的表达及意义[J].中国老年学杂志,2010,30(10):1407-1409. 被引量:7
  • 10胃癌HER2检测指南[J].中华病理学杂志,2011,40(8):553-557. 被引量:98

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部